Jodi Moriguchi

962 total citations
13 papers, 335 citations indexed

About

Jodi Moriguchi is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Jodi Moriguchi has authored 13 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Hepatology and 5 papers in Oncology. Recurrent topics in Jodi Moriguchi's work include Liver physiology and pathology (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jodi Moriguchi is often cited by papers focused on Liver physiology and pathology (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jodi Moriguchi collaborates with scholars based in United States. Jodi Moriguchi's co-authors include Paula Kaplan‐Lefko, Angela Coxon, Teresa L. Burgess, Yihong Zhang, Karen Rex, Isabelle Dussault, Yajing Yang, Yan Gu, Carol W. Johnson and Andrew S. Tasker and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Jodi Moriguchi

12 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jodi Moriguchi United States	6	220	107	103	59	54	13	335
Mally Romero United States	4	364 1.7×	121 1.1×	143 1.4×	46 0.8×	53 1.0×	5	475
Tracy Lou United States	3	209 0.9×	115 1.1×	90 0.9×	65 1.1×	57 1.1×	3	334
Ben Staal United States	9	219 1.0×	55 0.5×	140 1.4×	21 0.4×	62 1.1×	14	365
Lany Ruslim United States	6	308 1.4×	240 2.2×	155 1.5×	83 1.4×	86 1.6×	6	514
Nooreen Rubin United States	5	291 1.3×	54 0.5×	53 0.5×	28 0.5×	52 1.0×	6	408
Steven Do United States	7	293 1.3×	240 2.2×	154 1.5×	104 1.8×	86 1.6×	10	499
Tao Osgood United States	6	158 0.7×	51 0.5×	185 1.8×	32 0.5×	58 1.1×	14	308
Shinji Oie Japan	12	315 1.4×	48 0.4×	140 1.4×	61 1.0×	39 0.7×	22	515
K. Papadopoulos United States	11	236 1.1×	61 0.6×	198 1.9×	62 1.1×	136 2.5×	46	462
Vincenzo Ricci Italy	11	158 0.7×	51 0.5×	313 3.0×	76 1.3×	123 2.3×	33	477

Countries citing papers authored by Jodi Moriguchi

Since Specialization

Citations

This map shows the geographic impact of Jodi Moriguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi Moriguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi Moriguchi more than expected).

Fields of papers citing papers by Jodi Moriguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi Moriguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi Moriguchi. The network helps show where Jodi Moriguchi may publish in the future.

Co-authorship network of co-authors of Jodi Moriguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi Moriguchi. A scholar is included among the top collaborators of Jodi Moriguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi Moriguchi. Jodi Moriguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Belmontes, Brian, et al.. (2023). Abstract 6246: The MTA-cooperative PRMT5 inhibitor AM-9747 exhibits robust antitumor activity in combination with clinically relevant chemotherapies and targeted agents in MTAP null tumor models. Cancer Research. 83(7_Supplement). 6246–6246.

Belmontes, Brian, Siyuan Liu, Jodi Moriguchi, et al.. (2022). Abstract 1807: The discovery and preclinical characterization of the MTA cooperative PRMT5 inhibitor AM-9747. Cancer Research. 82(12_Supplement). 1807–1807. 4 indexed citations

Moriguchi, Jodi, et al.. (2017). Response-Derived Input Function Estimation for Dynamic Contrast-Enhanced MRI Demonstrated by Anti-DLL4 Treatment in a Murine U87 Xenograft Model. Molecular Imaging and Biology. 19(5). 673–682. 1 indexed citations

Hughes, Paul E., Karen Rex, Sean Caenepeel, et al.. (2016). In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models. Molecular Cancer Therapeutics. 15(7). 1568–1579. 44 indexed citations

Moody, Gordon, Jodi Moriguchi, Ji-Rong Sun, et al.. (2015). Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR. Journal for ImmunoTherapy of Cancer. 3(S2). 1 indexed citations

Hughes, Paul E., Yajing Yang, Karen Rex, et al.. (2014). Abstract 728: AMG 337, a novel, potent and selective MET kinase inhibitor, has robust growth inhibitory activity in MET-dependent cancer models. Cancer Research. 74(19_Supplement). 728–728. 6 indexed citations

Coxon, Angela, Paula Kaplan‐Lefko, Stephen A. Kaufman, et al.. (2012). Abstract LB-311: Inhibition of angiopoietin and Dll4 signaling in the tumor vasculature leads to increased efficacy in mouse tumor xenograft models. Cancer Research. 72(8_Supplement). LB–311. 1 indexed citations

Kaplan‐Lefko, Paula, Jonathan D. Graves, Stephen J. Zoog, et al.. (2010). Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types. Cancer Biology & Therapy. 9(8). 618–631. 100 indexed citations

Zoog, Stephen J., Paula Kaplan‐Lefko, Jodi Moriguchi, et al.. (2010). Measurement of conatumumab‐induced apoptotic activity in tumors by fine needle aspirate sampling. Cytometry Part A. 77A(9). 849–860. 14 indexed citations

10.

Zhang, Yihong, Paula Kaplan‐Lefko, Karen Rex, et al.. (2008). Identification of a Novel Recepteur d'Origine Nantais/c-Met Small-Molecule Kinase Inhibitor with Antitumor Activity In vivo. Cancer Research. 68(16). 6680–6687. 47 indexed citations

11.

Coxon, Angela, Karen Rex, Jan Sun, et al.. (2008). Exploratory biomarkers in the HGF/SF:c-Met axis: preclinical and clinical results. Cancer Research. 68. 2804–2804. 2 indexed citations

12.

Zhang, Yihong, Paula Kaplan‐Lefko, Karen Rex, et al.. (2007). Identification and characterization of a novel RON/c-Met small molecule inhibitor. Molecular Cancer Therapeutics. 6. 2 indexed citations

13.

Bellon, Steven F., Paula Kaplan‐Lefko, Yajing Yang, et al.. (2007). c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations. Journal of Biological Chemistry. 283(5). 2675–2683. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact